Radiculopathy near Teaneck, NJ

Biography: Dr. Manubay has a background in Family Medicine, and completed a post-doctoral fellowship in Substance Abuse at Columbia University. Afterward, she joined our Division as a junior faculty member working with Dr. Maria Sullivan and Dr. Sandra Comer, primarily focusing on research of opioid dependence. She continues to provide supervision and medical coverage for research studies in our Division. In addition, she has extensive clinical experience with MAT with buprenorphine and was the Medical Director of the Buprenorphine Program of Columbia University from 2008-2011. She is also the Clinical Director of the Opioid Overdose Prevention Program at NYSPI, and for all of the Ambulatory Care Network outpatient clinics at both NYP-Columbia and Cornell campuses. As a part-time faculty member in the Department of Family Medicine at New York Presbyterian Hospital-Columbia, she works at the outpatient office, Farrell Clinic, and teaches medical students and residents. Her interests are in opioid research and in implementing MAT in the outpatient clinics to help expand care to more individuals with opioid use disorder.

Biography: Dr. Philip L. De Jager is professor of neurology. After graduating from Yale University with a degree in Molecular Biophysics & Biochemistry, Dr. De Jager received a PhD in Neurogenetics from Rockefeller University and an MD from Cornell University Medical College, before completing his MMSc in Clinical Investigation at Harvard Medical School (HMS) and MIT. He served as a neurology resident in the Partners Neurology Residency Program at the Massachusetts General Hospital and Brigham and Women's Hospital. He then joined the faculty at HMS, rising to the rank of associate professor before joining CUIMC. The goal of Dr. De Jager's work as a clinician-scientist is to apply modern methods of neuro-immunology, statistical genetics, and systems biology to the understanding of common neurodegenerative diseases. At CUIMC, Dr. De Jager serves as Chief of the Department of Neurology's Division of Neuroimmunology, which includes the Columbia University Multiple Sclerosis Center and focuses on characterizing and targeting the neuro-immunologic component of neurodegenerative disease. Dr. De Jager also serves as the director of a new Center for Translational & Computational Neuro-Immunology.

Biography: Dr. Claire Riley earned an undergraduate degree from Dartmouth College and a medical degree from Vagelos College of Physicians and Surgeons (VP&S). She completed an internship in internal medicine and her residency in neurology at Columbia University Irving Medical Center. In addition, she completed a two-year clinical fellowship in the Columbia University Multiple Sclerosis Center in 2010. Dr. Riley is board certified in neurology by the American Board of Psychiatry and Neurology. Dr. Riley is the Director of the Columbia MS Center, where she has led the clinical team since January 2012. She was previously the Clinical Director of the Yale MS Center in New Haven, CT. Dr. Riley regularly teaches medical students, residents and fellows in the MS clinic. She is also an investigator in clinical trials related to multiple sclerosis and is particularly interested in furthering treatments for progressive MS. Columbia University's Multiple Sclerosis Center is a premier treatment and research facility for individuals living with multiple sclerosis. Our center remains dedicated to providing the most advanced diagnostic and therapeutic care available to our patients.